|
⚲
|
| Keyboard |
| Belldegrun Arie
✚
|
|
|---|---|
| CIK # | 0001296549 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001296549] | |
| 4 | [0001296549] | |
| 5 | [0001296549] | |
| SC 13D | [0001296549] | |
| SC 13G | [0001296549] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Belldegrun Arie | Allogene Therapeutics Inc | [2019-02-13] |
| Belldegrun Arie | Arno Therapeutics Inc | [2016-09-08] |
| Belldegrun Arie | Kite Pharma Inc | [2015-02-11] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| UroGen Pharma Ltd | |
| Belldegrun Arie | |
| Allogene Therapeutics Inc | |
| Kronos Bio Inc | |
| Ginkgo Bioworks Holdings Inc | |
| Kite Pharma Inc | |
| Arno Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Allogene Therapeutics Inc ALLO
Stock Option (Right to buy) · derivative
|
2026-02-02 | Grant | 929,913 | $0.00 | |
|
Allogene Therapeutics Inc ALLO
Restricted Stock Unit · derivative
|
2026-02-02 | Grant | 263,033 | $0.00 | |
|
Kronos Bio Inc KRON
Common Stock
|
2025-06-20 | Tender | 679,575 | $0.57 | 387,358 |
|
Kronos Bio Inc KRON
Common Stock
|
2025-06-20 | Tender | 2,765,314 | $0.57 | 1,576,229 |
|
Kronos Bio Inc KRON
Stock Option (Right to Buy) · derivative
|
2025-06-20 | Disposed to issuer | 34,000 | $0.00 | |
|
Kronos Bio Inc KRON
Stock Option (Right to Buy) · derivative
|
2025-06-20 | Disposed to issuer | 34,000 | $0.00 | |
|
Kronos Bio Inc KRON
Stock Option (Right to Buy) · derivative
|
2025-06-20 | Disposed to issuer | 34,000 | $0.00 | |
|
Kronos Bio Inc KRON
Stock Option (Right to Buy) · derivative
|
2025-06-20 | Disposed to issuer | 20,600 | $0.00 | |
|
Allogene Therapeutics Inc ALLO
Common Stock
|
2025-01-24 | Grant | 369,957 | $0.00 | |
|
Allogene Therapeutics Inc ALLO
Stock Option (Right to buy) · derivative
|
2025-01-24 | Grant | 1,307,927 | $0.00 | |
|
UroGen Pharma Ltd URGN
Stock Option (right ot buy) · derivative
|
2024-08-06 | Grant | 10,000 | $0.00 | |
|
Kronos Bio Inc KRON
Stock Option (Right to Buy) · derivative
|
2024-06-25 | Grant | 34,000 | $0.00 | |
|
Ginkgo Bioworks Holdings Inc DNA
Restricted Stock Units · derivative
|
2024-06-13 | Grant | 432,900 | $0.00 | |
|
Ginkgo Bioworks Holdings Inc DNA
Stock Option · derivative
|
2024-06-13 | Grant | 571,428 | $0.00 | |
|
Ginkgo Bioworks Holdings Inc DNA
Class A Common Stock
|
2024-06-12 | Option exercise | 105,263 | ||
|
Ginkgo Bioworks Holdings Inc DNA
Restricted Stock Units · derivative
|
2024-06-12 | Option exercise | 105,263 | ||
|
Allogene Therapeutics Inc ALLO
Common Stock
|
2024-05-16 | Buy | 1,724,137 | $2.90 | 4,999,997 |
|
Allogene Therapeutics Inc ALLO
Common Stock
|
2024-05-16 | Grant | 344,828 | $2.90 | 1,000,001 |
|
Allogene Therapeutics Inc ALLO
Common Stock
|
2024-01-25 | Grant | 211,973 | $0.00 | |
|
Allogene Therapeutics Inc ALLO
Stock Option (Right to buy) · derivative
|
2024-01-25 | Grant | 749,398 | $0.00 | |
| showing 20 of 177 most recent transactions | |||||